Stay updated on Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Version 5 (2023-03-07) was added to the history, updating Recruitment Status, Study Status, and Study Design. This revision reflects the trial's current activity and design details.
    Difference
    0.1%
    Check dated 2025-11-03T11:40:21.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    - Updated the page to v3.2.0 and added a government-operational status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.
    Difference
    12%
    Check dated 2025-10-05T17:22:13.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No other substantive content changes are indicated.
    Difference
    0.3%
    Check dated 2025-09-28T10:12:50.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page version updated from v3.0.1 to v3.0.2, signaling a minor content update; the 'Back to Top' link was removed, a minor UI change.
    Difference
    0.7%
    Check dated 2025-09-14T00:17:28.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.7%
    Check dated 2025-09-06T21:11:48.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while several location-related details have been removed.
    Difference
    8%
    Check dated 2025-08-30T15:34:08.000Z thumbnail image

Stay in the know with updates to Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.